Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses
Eli Lilly has been on an acquisition spree this year. After buying
Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...
Impressions : 1596
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.